Exam 2 lecture 5 (colorectal) Flashcards

1
Q

How is colon cancer ranked in terms of incidence and death in men and women? Where is incidence high?

A

3rd in incidence an death for both. Incidence high in industrialized nations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

risk factors for colon cancer

A

Age- increases strating age 40. is greater after 50.
FH
dietary factors (high fat, low fiber
polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a hereditary syndrome that puts people at risk of colon cancer? WHen does screening start for this condition?

A
  1. Familial adenomatous polyposis (FAP)
    (development of 1000s of adenomatous polyps. 100% life time risk for colon cancer.
    screening starts at 10-12 yrs old
  2. Hereditary nonpolyposis colorectal cancer (HNPCC)
    early age of onset (40-45)
    80& risk of cancer development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are warning signs of colon cancer?

A

Constipation
diarrhea
blood in stools
narrow stools
unexplained anemia
abdominal pain
weight loss
weakness/fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is colorectal cancer presented

A

May be asymptomatic
Presents with rectal bleeding with anemia.
N/v
20-25% will present with metastatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

all patients with colon cancer should be tested for what

A

defective mismatch repair (dMMR) and microsatalite- high level instability (MSI-H)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do dMMR or MSI-H tumors predict?

A

Predict decreased benefit from adjuvant 5-FU based therapy for STAGE II disease

stage III patients with dMMR or MSI-H disease CAN BENEFIT from adjuvant 5-FU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the treatment options for colorectal cancer

A

surgery
radiation therapy
chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how to treat stage I and II colon cancer

A

surgery alone is definitive therapy for stage I and stage II with MSI-h and/or MMR.

for stage II without MSI and/or MMR we do surgery and chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

WHat chemo options for stage II colon cancer without MMR and MSI-h? What do they stand for?

A

FOLFOX and capeOX

FOLFOX- 5-FU, leucovorin and oxaliplatin (for high/intermediate risk stage II pts)
capeOX- capecitabine, oxaliplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How to treat stage III colon cancer

A

surgery (regional lymph node removal)
chemotherapy is indicated for this stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the chemo options for stage III colon cancer

A

FOLFOX
capeOX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the regimen for stage III colon cancer depending on the risk

A

low risk- capeOX 3 months or FOLFOX 3-6 months

High risk- capeox for 3-6 months
FOLFOX for 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some regimen considerations when choosing between FOLFOX and capeOX for colon cancer

A

FOLFOX- requires port, 2-day pump, more infusions overall, increased myelosuppression and mouth sores

capeOX- port not required, less infusion overall, increased hand foot syndrome, capecitabine has renal dose adjustment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is advanced/metastatic colon cancer treated? WHat do we take into consideration

A

Chermotherapy is mainstay in colon cancer.
FOLFOX, capeOX, FOLFIRI, FOLFIRINOX (+ bevacizumab)

UGT1A1 deficiency and neuropathy are things we take into consideration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

for advanced colon cancer with either UGT1A1 and neuropathy

A

UGT1a1 deficiency- we do NOT use irinotecan
neuropathy- we would NOT use oxaloplatin

17
Q

How do we treat advanced colon cancer with MMR or MSI-H

A

FOLFOX/FOLFIRI

with

pembrolizumab and nivolumab

18
Q

What drugs do we give with KRAS wild type (WT) and never with KRAS mutation with advanced metastatic colon cancer

A

cetuximab or panitumumab

19
Q

What are some accepted chemo regimens if someone can not tolerate intensive chemo

A

no targetable mutations- 5-FU + leucovorin (capecitabine +/- bevacizumab)

KRAS WT, left sided- cetuximab/panitumumab

dMMR/MSI-H nivolumab +/- ipilimumab with pembrolizumab

HER2 positive- trastuzumab + (pertuzumab or lapatinib or tucatinib)

20
Q

2nd line therapy for advanced colon cancer

A

Basically just switch therapy (i.e if they already received oxaliplatin based regimen, give irinotecan regimen like FOLFIRI

if patient was started on irinotecan regimen, give oxaliplatin based regimens (FOLFOX)

21
Q

What are side effects with 5-FU? What enhances its effects?

A

diarrhea. mucositis, myelosuppression

leucovorin enhances its effects

22
Q

side effects of oxaliplatin

A

cold intolerance, neuropathy

23
Q

Bevacizumab side effects

A

bleeding and high blood pressure (elevated BP may cause holding of drug that day), proteinuria

24
Q

what are colon cancer screening tests

A
  1. primarily detect cancer
    - fecal occult blood test (FOBT) and fecal immunohistochemical test (FIT)

or

  1. Detect cancer and advanced lesions
    - endoscopic and radiologic exams
25
Q

cons about FOBT? How to avoid them?

A

has high false negative rate

to avoid false negatives- avoid red meat and raw vegetables 3 days prior to testing

avoid vitamin C supplements and citrusy juices and fruits 3 days prior to testing

AVoid aspirin/NSAIDs, enemas

avoid testing until after 3 days after menstrual bleeding ended and avoud testing if hemmorhoids present

26
Q

What type of tests are FIT and FOBT? Compare them

A

Test to primarily detect colon cancer ( not advance dlesions)

FIT has no false negative rate

27
Q

What are tests to primarily detect cancer and advanced lesions

A

Endoscopy and colonoscopy

28
Q

screening guidelines for colon cancer for average risk, FH, HNPCC and FAP?

A

Average risk- start 45 yo, annual FOBT or FIT or colonoscopy every 10 years

FH- annual screening at age 40

HNPCC- annual screening age 20-25

FAP- annual screening age 10-12

29
Q

Colon cancer prevention

A

High fiber, low fat diet

calcium rich diet

aspirin/NSAID

colectomy

30
Q

MOA of 5-FU? What is it metabolized by in body? Common toxicities?

A

moa- 5-FU is converted invitro to FTUP and FDUMP.
FDUMP binds thymidylate synthase (TS) and reduces rate of DNA synthesis, replication and repair.

it is extensively metabolized by DPD in liver. Pts with DPD deficiency have exaggerated toxicities.

toxicities- diarrhea, mucositis, myelosuppression

31
Q

What is the prodrug of irinotecan? What are the dose limiting toxicities? What is a side effect that is very prevalent with this drug? WHat causes increased toxicity with irinotecan

A

Prodrug- SN-38
Dose limiting toxicities are diarrhea and neutropenia

Early onset diarrhea and late onset diarrhea are big side effects of the drug (early can happen while patient is receiving drug)

late inset starts more than 24 hrs after irinotecan administration. Start anti diarrheal treatment for both these

UGT1a1 deficiency causes increased toxicity

32
Q

what is capecitabine? Dose limiting toxicity?

A

dose limiting side effects- Hand foot syndrome and diarrhea
Oral prodrug of 5-FU

33
Q

Unique toxicity of oxaliplatin

A

COld intolerance, neuropathy and sensation of not being able to breathe

34
Q

WHat is cetuxaimab used in? Adverse effects?

A

Only used in KRAS wildtype patients

advrese events include acne form rash and hypomagnesemia

35
Q

what does panitumumab bind to? toxicity?

A

binds to EGFR
dane toxicity as cetuximab (acneform rash and hypomagnesemia)

36
Q
A